Tag: Syphilis
2016 to 2022 Saw Increase in Rate of Maternal Syphilis
Syphilis rate increased for all maternal race and Hispanic-origin groups, in all age groups, for all prenatal care categories
Recommendations Developed for Tests to Support Diagnosis of Syphilis
Laboratory tests for T. pallidum categorized into nontreponemal, treponemal tests; both needed to help differentiate untreated from past treated infection
2022 Saw More Than 2.5 Million Cases of Chlamydia, Gonorrhea, Syphilis
Concerns center around syphilis and congenital syphilis, which increased 17.0 and 30.6 percent in one year
Amid Shortage of Bicillin, FDA to Import Another Syphilis Drug
Paris-based Laboratoires Delbert is working with the FDA to temporarily import 3.5 million units of Extencilline
One in Four Young Sexual-, Gender-Minority Individuals May Experience Syphilis
Lifetime prevalence even higher for some subpopulations
Pfizer Warns of Shortage of Antibiotic Used to Fight Syphilis
Reasons for scarcity of Bicillin L-A include increasing demand because of the rising number of syphilis infections
Pfizer Warns of Looming Shortage of Long-Acting Penicillin for Children
Company says there is impending shortages of Bicillin, with pediatric versions of the shot likely to run out by the end of June
2021 Syphilis Rates Increased by Nearly One-Third in the United States
More than 2.5 million cases of chlamydia, gonorrhea, and syphilis were reported in 2021
USPSTF Recommends Syphilis Screening for At-Risk Persons
Substantial net benefit observed for screening of nonpregnant persons at increased risk for infection
USPSTF Still Advises Syphilis Screening for At-Risk Teens, Adults
Grade A recommendation reaffirms 2016 recommendation for asymptomatic, nonpregnant adults and teens at increased risk
